Is NVO a good stock to buy?

Is NVO a Buy, Sell or Hold? Novo Nordisk has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.

Where will NVO stock be in 5 years?

Novo Nordisk stock price stood at $135.31 According to the latest long-term forecast, Novo Nordisk price will hit $150 by the middle of 2025 and then $200 by the middle of 2026 . Novo Nordisk will rise to $250 within the year of 2028, $300 in 2029, $350 in 2033 and $400 in 2035.

What is the future forecast for NVO stock?

According to our current NVO stock forecast, the value of Novo Nordisk A/S shares will rise by 4.57% and reach $ 140.21 per share by June 2, 2024. Per our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).

What is the analyst rating for NVO stock?

Analyst Ratings 3M Ago Current Hold 9 8 Underweight 1 2 Sell 2 1 Consensus Overweight Overweight 2 more rows

Is it smart to invest in Novo Nordisk?

Novo Nordisk stock has a consensus "Moderate Buy" rating . Out of 13 analysts offering recommendations for the stock, nine recommend a "Strong Buy," one suggests a "Moderate Buy," two advise a "Hold" rating, and one gives a "Moderate Sell."

Intrinsic Value. The intrinsic value of one NVO stock under the Base Case scenario is 92.78 USD. Compared to the current market price of 134.08 USD, Novo Nordisk A/S is Overvalued by 31% .

What is the prediction for Novo Nordisk in 2024?

Novo Nordisk raised its outlook for 2024, nudging its sales growth outlook range one percentage point higher, to 19% to 27% at constant exchange rates. It also upped its operating growth forecast to 22% to 30% from a previous forecast of 21% to 29%.

What is the future outlook for Novo Nordisk?

Novo Nordisk expects that the acquisition will be completed towards the end of 2024 . For the 2024 outlook, sales growth is now expected to be 19-27% at CER, and operating profit growth is now expected to be 22-30% at CER.

Will Novo Nordisk continue to grow?

Moreover, Novo Nordisk management expects its total sales in 2024 to grow by 18% to 26% relative to 2023 , even in the face of increased competition in the global insulin market, as well as the negative impact of Biden's Inflation Reduction Act.

Is Viking Therapeutics a good buy?

Viking Therapeutics currently has an average brokerage recommendation (ABR) of 1.00, on a scale of 1 to 5 (Strong Buy to Strong Sell ), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 10 brokerage firms. An ABR of 1.00 indicates Strong Buy.

Why the Stock Is Falling. Novo Nordisk shares slipped on Thursday after sales of the company's weight-loss drug Wegovy fell short of estimates in the first quarter of the year .

Is Omega Healthcare investors a buy?

Omega Healthcare has a consensus rating of Hold which is based on 2 buy ratings, 6 hold ratings and 0 sell ratings. The average price target for Omega Healthcare is $33.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.

What is the Zacks rating of NVO?

NVO is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors.

Novo Nordisk A/S (NVO) Stock Historical Prices & Data

Time Period:

Apr 03, 2023 - Apr 03, 2024

Show:

Historical Prices

Frequency:

Daily

Currency in USDDownload

Date	Open	High	Low	Close*	Adj Close**	Volume
Apr 03, 2024	125.38	128.13	125.38	126.99	126.99	3,609,735
Apr 02, 2024	125.05	126.68	124.08	126.46	126.46	4,322,400
Apr 01, 2024	129.11	129.11	127.15	127.55	127.55	3,065,100
Mar 28, 2024	128.39	130.16	127.79	128.40	128.40	3,656,500
Mar 27, 2024	128.33	128.62	127.29	128.05	128.05	3,941,200
Mar 26, 2024	130.10	130.16	128.44	129.41	129.41	4,218,200
Mar 25, 2024	129.00	130.25	128.71	129.05	129.05	3,320,000
Mar 22, 2024	129.22	129.49	128.11	128.76	128.76	3,225,800
Mar 22, 2024	0.93 Dividend
Mar 21, 2024	129.00	131.07	127.11	129.83	128.90	6,548,800
Mar 20, 2024	131.15	131.43	128.83	130.36	129.43	4,403,900
Mar 19, 2024	132.04	132.21	130.51	131.37	130.43	4,393,500
Mar 18, 2024	131.57	133.75	131.07	132.89	131.94	3,898,800
Mar 15, 2024	133.88	134.00	131.86	132.37	131.42	3,777,700
Mar 14, 2024	135.85	135.92	133.87	134.58	133.62	3,506,900
Mar 13, 2024	134.24	135.50	132.70	133.49	132.53	6,847,000
Mar 12, 2024	131.60	135.12	131.45	135.11	134.14	6,340,600
Mar 11, 2024	133.37	133.52	130.75	131.24	130.30	5,734,500
Mar 08, 2024	133.90	134.83	131.10	133.07	132.12	12,725,100
Mar 07, 2024	133.44	138.28	132.87	135.92	134.95	19,606,800
Mar 06, 2024	124.36	125.18	123.36	124.75	123.86	3,895,500
Mar 05, 2024	126.25	126.83	123.97	124.65	123.76	4,807,800
Mar 04, 2024	127.33	128.77	126.99	127.95	127.03	6,816,900
Mar 01, 2024	122.80	124.43	122.25	124.23	123.34	5,559,600
Feb 29, 2024	120.11	120.28	118.91	119.77	118.91	5,479,800
Feb 28, 2024	121.96	122.15	120.93	121.54	120.67	3,075,200
Feb 27, 2024	119.97	122.56	119.79	122.23	121.35	7,637,000
Feb 26, 2024	123.20	124.17	122.79	123.49	122.61	4,451,800
Feb 23, 2024	123.67	124.17	122.91	123.45	122.57	3,759,400
Feb 22, 2024	123.07	124.87	123.01	124.52	123.63	3,589,500
Feb 21, 2024	119.00	120.99	118.30	120.93	120.06	4,122,300
Feb 20, 2024	124.62	124.76	120.72	121.45	120.58	5,070,400
Feb 16, 2024	121.84	124.64	121.55	124.01	123.12	6,607,200
Feb 15, 2024	122.78	123.15	121.09	121.75	120.88	4,764,000
Feb 14, 2024	120.51	123.34	120.38	123.29	122.41	5,678,200
Feb 13, 2024	119.66	120.55	119.43	119.99	119.13	4,186,600
Feb 12, 2024	120.42	120.85	119.29	120.53	119.67	4,497,800
Feb 09, 2024	120.00	121.65	119.48	121.20	120.33	5,294,500
Feb 08, 2024	118.05	118.63	117.51	118.39	117.54	4,544,700
Feb 07, 2024	116.97	119.67	116.81	118.66	117.81	6,206,000
Feb 06, 2024	118.33	118.70	116.66	117.61	116.77	6,274,900
Feb 05, 2024	116.39	118.60	116.27	118.26	117.41	8,730,300
Feb 02, 2024	113.76	114.60	113.24	113.70	112.89	5,136,000
Feb 01, 2024	114.00	115.86	113.34	115.79	114.96	6,837,200
Jan 31, 2024	112.15	116.12	112.15	114.74	113.92	12,716,100
Jan 30, 2024	109.19	109.33	108.46	109.02	108.24	5,105,000
Jan 29, 2024	108.13	109.02	107.70	109.02	108.24	3,915,900
Jan 26, 2024	106.53	108.20	106.42	108.07	107.30	5,544,700
Jan 25, 2024	105.73	105.73	104.81	105.68	104.92	2,275,100
Jan 24, 2024	106.65	107.03	105.21	105.21	104.46	2,537,500
Jan 23, 2024	103.70	105.49	103.38	105.37	104.62	8,654,600
Jan 22, 2024	106.32	106.61	105.49	105.49	104.73	2,907,000
Jan 19, 2024	107.19	107.91	106.50	106.96	106.19	3,572,000
Jan 18, 2024	106.30	107.70	105.92	107.55	106.78	3,364,500
Jan 17, 2024	106.32	107.11	105.54	106.68	105.92	2,685,800
Jan 16, 2024	106.86	107.04	105.86	106.35	105.59	3,131,300
Jan 12, 2024	106.94	107.47	106.72	107.16	106.39	3,582,900
Jan 11, 2024	108.31	108.69	105.98	106.69	105.93	5,021,300
Jan 10, 2024	107.83	108.77	107.68	108.67	107.89	4,725,900
Jan 09, 2024	106.13	106.97	105.72	106.95	106.18	3,681,100
Jan 08, 2024	106.18	106.54	105.27	106.40	105.64	2,880,700
Jan 05, 2024	106.56	107.19	105.72	105.98	105.22	3,974,100
Jan 04, 2024	105.11	108.98	105.03	107.63	106.86	9,132,800
Jan 03, 2024	102.05	103.84	102.03	103.62	102.88	4,064,100
Jan 02, 2024	101.71	102.63	101.71	102.11	101.38	2,637,400
Dec 29, 2023	103.55	103.68	102.73	103.45	102.71	2,055,900
Dec 28, 2023	104.55	104.99	103.47	103.47	102.73	2,380,100
Dec 27, 2023	102.66	103.81	102.35	103.68	102.94	2,254,900
Dec 26, 2023	102.56	103.13	102.41	102.68	101.94	1,851,400
Dec 22, 2023	103.16	103.56	102.58	102.71	101.97	2,211,100
Dec 21, 2023	102.86	103.48	102.57	103.48	102.74	3,608,900
Dec 20, 2023	101.20	102.87	101.05	101.31	100.58	5,389,600
Dec 19, 2023	99.88	100.60	99.54	99.99	99.27	3,497,000
Dec 18, 2023	99.52	99.80	98.52	98.98	98.27	4,724,300
Dec 15, 2023	97.53	97.53	96.53	97.10	96.40	5,230,000
Dec 14, 2023	98.52	98.73	96.96	98.00	97.30	5,689,000
Dec 13, 2023	96.93	98.93	96.84	98.90	98.19	5,528,200
Dec 12, 2023	95.05	96.33	94.96	96.21	95.52	3,642,400
Dec 11, 2023	96.43	97.09	94.73	96.65	95.96	5,039,600
Dec 08, 2023	96.40	97.05	96.22	96.64	95.95	3,599,100
Dec 07, 2023	97.28	97.30	95.74	96.81	96.12	3,424,800
Dec 06, 2023	99.25	99.26	97.59	97.59	96.89	3,082,100
Dec 05, 2023	99.37	99.88	98.91	99.63	98.92	2,846,000
Dec 04, 2023	100.57	101.15	99.58	100.92	100.20	2,988,000
Dec 01, 2023	101.10	101.76	100.31	100.40	99.68	4,565,700
Nov 30, 2023	101.49	101.99	101.01	101.84	101.11	2,671,100
Nov 29, 2023	101.55	102.31	100.86	102.00	101.27	2,664,600
Nov 28, 2023	101.87	102.25	101.03	101.43	100.70	5,147,700
Nov 27, 2023	104.88	105.44	103.69	103.87	103.13	4,746,000
Nov 24, 2023	104.23	105.69	104.15	105.45	104.69	4,598,700
Nov 22, 2023	103.06	103.71	102.14	103.26	102.52	2,692,000
Nov 21, 2023	103.36	103.62	101.86	102.78	102.04	4,088,000
Nov 20, 2023	101.50	103.74	101.49	103.59	102.85	4,618,300
Nov 17, 2023	101.25	101.71	100.55	101.39	100.66	3,806,800
Nov 16, 2023	98.96	99.63	98.11	99.53	98.82	5,080,600
Nov 15, 2023	98.30	98.81	96.00	96.43	95.74	7,039,300
Nov 14, 2023	99.70	99.79	98.51	99.20	98.49	5,477,000
Nov 13, 2023	99.45	101.97	97.77	100.78	100.06	8,415,000
Nov 10, 2023	100.20	101.41	98.52	101.19	100.47	5,638,600
Nov 09, 2023	100.87	101.65	99.75	100.03	99.31	4,482,900
Close price adjusted for splits.*Adjusted close price adjusted for splits and dividend and/or capital gain distributions.

Loading more data...

Novo Nordisk A/S (NVO) Stock Historical Prices & Data - Yahoo Finance (2024)

FAQs

Is NVO a good stock to buy? ›

Why is NVO falling? ›

	3M Ago	Current
Hold	9	8
Underweight	1	2
Sell	2	1
Consensus	Overweight	Overweight